サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1485794

プラスミドDNA製造市場：グレード別、用途別、開拓段階別、疾患別、国別、地域別-産業分析、市場規模、市場シェア、2024-2032年の予測

Plasmid DNA Manufacturing Market, By Grade, By Application, By Development Phase, By Disease, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 399 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
プラスミドDNA製造市場：グレード別、用途別、開拓段階別、疾患別、国別、地域別-産業分析、市場規模、市場シェア、2024-2032年の予測
出版日: 2024年04月13日
発行: AnalystView Market Insights
ページ情報: 英文 399 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

プラスミドDNA製造市場規模は2023年に17億8,898万米ドルとなり、2024年から2032年にかけてCAGR 21.5%で拡大

プラスミドDNA製造市場-市場力学

研究開発活動の活発化、遺伝性疾患や感染症の流行の高まりが市場需要を促進

研究開発活動の増加、バイオ医薬品への投資の増加、遺伝子異常や感染症の頻度の上昇など、さまざまな理由がプラスミドDNA製造市場を牽引しています。さらに、精密医療への動きや新たな免疫療法の開発が、プラスミドDNAベースの医薬品需要を押し上げています。規制の進歩や承認手続きの短縮が市場拡大を後押しし、研究の発見をより迅速に臨床応用に結びつけることを可能にしています。

プラスミドDNA製造市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約21.5%のCAGRで毎年成長すると推定されます。

市場セグメンテーションによると、2023年にはR&Dグレードが最大の市場シェアを占めると予測されています。

用途別では、DNAワクチンが2023年の主要タイプ

開発段階別では、2023年には臨床前治療薬が主要タイプとなっています。

地域別では、北米が2023年の売上高でトップ

プラスミドDNA製造市場-セグメンテーション分析：

世界のプラスミドDNA製造市場は、グレード、用途、開拓段階、疾患、地域に基づいて区分されます。

市場はグレードによって3つのカテゴリーに分けられる：R&Dグレード、GMPグレード。R&Dグレード分野が市場を独占しています。研究開発の初期段階で広く使用されるR&DグレードのプラスミドDNAは、科学者が新しい治療コンセプトを探求し、前臨床での有効性を検証することを可能にします。

市場は用途によって2つのカテゴリーに分けられる：DNAワクチン、細胞・遺伝子治療、免疫療法、その他です。DNAワクチン分野は市場を独占しており、予測期間中もその優位性を維持するとみられます。病原体を認識して闘う免疫系の能力を活用するDNAワクチンは、感染症の予防や新たな健康脅威に対処するための有望なアプローチを提供します。

プラスミドDNA製造市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

プラスミドDNA製造市場-競合情勢：

プラスミドDNA製造市場は競争が激しく、著名な競合企業が斬新な製造プロセスやスケーラブルな生産能力によって覇権を争っています。各社は戦略的提携、買収、研究開発費を駆使して市場での地位を強化し、製品ラインナップの幅を広げています。大手企業は、遺伝子治療、ワクチン研究、バイオ医薬品製造など、さまざまな用途で拡大するプラスミドDNAの需要を満たすため、品質保証、規制遵守、コスト効率の高いソリューションを優先しています。競争優位性を維持するために、企業は常に変化する市場動向と顧客の需要に適応しなければならないです。

目次

第1章 プラスミドDNA製造市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 プラスミドDNA製造の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 プラスミドDNA製造産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 プラスミドDNA製造市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 プラスミドDNA製造市場情勢

  • プラスミド DNA製造市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 プラスミドDNA製造市場- グレード別

  • 概要
    • グレード別セグメントシェア分析
    • R&Dグレード
    • GMPグレード

第8章 プラスミドDNA製造市場- 開発段階別

  • 概要
    • 開発段階別セグメントシェア分析
    • 前臨床治療
    • 臨床治療
    • 市販されている治療薬

第9章 プラスミドDNA製造市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • DNAワクチン
    • 細胞・遺伝子治療
    • 免疫療法
    • その他

第10章 プラスミドDNA製造市場- 疾患別

  • 概要
    • 疾患別セグメントシェア分析
    • 感染症
    • がん
    • 遺伝性疾患
    • その他

第11章 プラスミドDNA製造市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- プラスミドDNA製造業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Nature Technology
    • Cell and Gene Therapy Catapult
    • Danaher（Aldevron）
    • Kaneka Corp.
    • Eurofins Genomics
    • Lonza
    • Charles River Laboratories
    • VGXI, Inc.
    • Luminous BioSciences, LLC
    • Akron Biotech
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Plasmid DNA Manufacturing Market: Grade Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Grade
  • TABLE Global Plasmid DNA Manufacturing Market, by Grade 2019-2032 (USD Million)
  • TABLE Plasmid DNA Manufacturing Market: Development Phase Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Development Phase
  • TABLE Global Plasmid DNA Manufacturing Market, by Development Phase 2019-2032 (USD Million)
  • TABLE Plasmid DNA Manufacturing Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Plasmid DNA Manufacturing Market, by Application 2019-2032 (USD Million)
  • TABLE Plasmid DNA Manufacturing Market: Disease Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Plasmid DNA Manufacturing Market, by Disease 2019-2032 (USD Million)
  • TABLE Plasmid DNA Manufacturing Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Plasmid DNA Manufacturing Market, by Region 2019-2032 (USD Million)
  • TABLE North America Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
  • TABLE North America Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
  • TABLE North America Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Europe Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
  • TABLE Europe Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
  • TABLE Europe Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
  • TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
  • TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Latin America Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
  • TABLE Latin America Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
  • TABLE Latin America Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Grade, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Development Phase, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Plasmid DNA Manufacturing Market, by Disease, 2019-2032 (USD Million)
目次
Product Code: ANV2696

REPORT HIGHLIGHT

Plasmid DNA Manufacturing Market size was valued at USD 1,788.98 Million in 2023, expanding at a CAGR of 21.5% from 2024 to 2032.

The Global Plasmid DNA Manufacturing Market is seeing substantial expansion and transition, owing to advances in biopharmaceutical study and development. Plasmid DNA, a flexible molecular tool, serves as the basis for a wide range of therapeutic applications, including DNA vaccinations, cell and gene therapy. As the need for personalised medicine and targeted therapies continues to develop, the market for plasmid DNA synthesis is positioned to significantly expand.

Plasmid DNA Manufacturing Market- Market Dynamics

Increasing research and development activities and the rising prevalence of genetic disorders and infectious diseases propel market demand

A variety of reasons are driving the Plasmid DNA Manufacturing marketplace, including increased R&D efforts, increased biopharmaceutical investments, and the rising frequency of genetic abnormalities and infectious illnesses. Furthermore, the move towards precision medicine and the development of new immunotherapies are driving up demand for plasmid DNA-based medicines. Regulatory advances and shortened approval procedures boost market expansion, allowing speedier translation of research discoveries into clinical applications.

Plasmid DNA Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.5% over the forecast period (2024-2032)

Based on Grade segmentation, R&D Grade was predicted to show maximum market share in the year 2023

Based on application segmentation, DNA Vaccines was the leading type in 2023

Based on Development Phase segmentation, Pre-Clinical Therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Plasmid DNA Manufacturing Market- Segmentation Analysis:

The Global Plasmid DNA Manufacturing Market is segmented based on Grade, Application, Development Phase, Disease, and Region.

The market is divided into three categories based on Grade: R&D Grade, GMP Grade. The R&D Grade sector dominates the market. Widely used in early-stage research and development, R&D Grade plasmid DNA enables scientists to explore novel therapeutic concepts and validate preclinical efficacy.

The market is divided into two categories based on application: DNA Vaccines, Cell & Gene Therapy, Immunotherapy, and Others. The DNA vaccine segment dominates the market and is likely to maintain its dominance during the forecast period. Leveraging the immune system's ability to recognize and combat pathogens, DNA vaccines offer a promising approach to preventing infectious diseases and addressing emerging health threats.

Plasmid DNA Manufacturing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Plasmid DNA Manufacturing Market- Competitive Landscape:

The Plasmid DNA Manufacturing Market is competitive, with prominent competitors vying for supremacy via novel manufacturing processes and scalable production capacity. Companies use strategic alliances, acquisitions, and R&D expenditures to strengthen their market position and broaden their product offerings. Leading companies prioritise quality assurance, regulatory compliance, and cost-effective solutions to fulfil the expanding demand for plasmid DNA in a variety of applications, including gene therapy, vaccine research, and biopharmaceutical manufacturing. To sustain their competitive advantage, businesses must constantly adapt to changing market trends and client demands.

Recent Developments:

In February 2023, PackGene Biotech expanded its services with the opening of an innovative GMP biomanufacturing and processing plant in Houston, Texas. This comprises gene therapy programmes that produce cost-effective, dependable, and scalable AAV products. With this development, the business hopes to become a one-stop solution supplier for gene therapy developers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMID DNA MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Nature Technology

Cell and Gene Therapy Catapult

Danaher (Aldevron)

Kaneka Corp.

Eurofins Genomics

Lonza

Charles River Laboratories

VGXI, Inc.

Luminous BioSciences, LLC

Akron Biotech

Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY GRADE- MARKET ANALYSIS, 2019 - 2032

  • R&D Grade
  • GMP Grade

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • DNA Vaccines
  • Cell & Gene Therapy
  • Immunotherapy
  • Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DEVELOPMENT PHASE- MARKET ANALYSIS, 2019 - 2032

  • Pre-Clinical Therapeutics
  • Clinical Therapeutics
  • Marketed Therapeutics

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

  • Infectious Disease
  • Cancer
  • Genetic Disorder
  • Others

GLOBAL PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Plasmid DNA Manufacturing Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Plasmid DNA Manufacturing Market Snippet by Grade
    • 2.1.2.Plasmid DNA Manufacturing Market Snippet by Development Phase
    • 2.1.3.Plasmid DNA Manufacturing Market Snippet by Application
    • 2.1.4.Plasmid DNA Manufacturing Market Snippet by Disease
    • 2.1.5.Plasmid DNA Manufacturing Market Snippet by Country
    • 2.1.6.Plasmid DNA Manufacturing Market Snippet by Region
  • 2.2.Competitive Insights

3.Plasmid DNA Manufacturing Key Market Trends

  • 3.1.Plasmid DNA Manufacturing Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Plasmid DNA Manufacturing Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Plasmid DNA Manufacturing Market Opportunities
  • 3.4.Plasmid DNA Manufacturing Market Future Trends

4.Plasmid DNA Manufacturing Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Plasmid DNA Manufacturing Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Plasmid DNA Manufacturing Market Landscape

  • 6.1.Plasmid DNA Manufacturing Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Plasmid DNA Manufacturing Market - By Grade

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Grade, 2023 & 2032 (%)
    • 7.1.2.R&D Grade
    • 7.1.3.GMP Grade

8.Plasmid DNA Manufacturing Market - By Development Phase

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Development Phase, 2023 & 2032 (%)
    • 8.1.2.Pre-Clinical Therapeutics
    • 8.1.3.Clinical Therapeutics
    • 8.1.4.Marketed Therapeutics

9.Plasmid DNA Manufacturing Market - By Application

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2.DNA Vaccines
    • 9.1.3.Cell & Gene Therapy
    • 9.1.4.Immunotherapy
    • 9.1.5.Others

10.Plasmid DNA Manufacturing Market - By Disease

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Development Phase, 2023 & 2032 (%)
    • 10.1.2.Infectious Disease
    • 10.1.3.Cancer
    • 10.1.4.Genetic Disorder
    • 10.1.5.Others

11.Plasmid DNA Manufacturing Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Plasmid DNA Manufacturing Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Plasmid DNA Manufacturing Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Plasmid DNA Manufacturing Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Plasmid DNA Manufacturing Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Plasmid DNA Manufacturing Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Grade, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Development Phase, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Plasmid DNA Manufacturing Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Nature Technology
    • 12.2.2.Cell and Gene Therapy Catapult
    • 12.2.3.Danaher (Aldevron)
    • 12.2.4.Kaneka Corp.
    • 12.2.5.Eurofins Genomics
    • 12.2.6.Lonza
    • 12.2.7.Charles River Laboratories
    • 12.2.8.VGXI, Inc.
    • 12.2.9.Luminous BioSciences, LLC
    • 12.2.10.Akron Biotech
    • 12.2.11.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us